Investigating Lipid Levels and Pain After Breast Cancer Surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to explore the relationship between lipid levels in blood samples and the intensity and duration of postoperative pain in women undergoing surgery for breast cancer. It will assess whether variations in circulating lipid mediators can predict chronic postoperative pain lasting more than three months. Additionally, the study will evaluate the activation of specific immune cells in the blood of participants. Women aged 18 and older with newly diagnosed breast cancer requiring surgical intervention will be enrolled.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women older than 18 years
* Newly diagnosed primary invasive or non-invasive breast cancer, requiring surgical excision of the tumor, with or without axillary surgery
* Able to give informed consent

Exclusion Criteria:

* Men
* Women aged less than 18 years
* Pregnant women
* History of major psychiatric disorders
* Previous breast or axillary surgery, recurrent disease or detectable metastatic disease at the time of diagnosis
* Unable to give informed consent

Where it's running

• Cliniques universitaires Saint-Luc (UCLouvain)
  Brussels, Brussels Capital, Belgium Recruiting

Study contacts

• Principal investigator: Mireille Alhouayek, PhD — Université Catholique de Louvain
• Study coordinator: Martine Berlière, MD, PhD
• Email: martine.berliere@saintluc.uclouvain.be
• Phone: 00327641075

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oncoliq blood test for early detection of breast cancer

  This project will test whether a blood-based miRNA panel (the Oncoliq Test) can detect early breast cancer in adults 40–70 by comparing newly diagnosed, untreated patients with cancer-free controls.

  Recruiting Oncoliq US Inc · Buenos Aires, Buenos Aires · NCT07331506

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• Palatal Shield Technique to Reduce Pain and Improve Healing After Free Gingival Graft

  This randomized trial tests whether a collagen sponge with a protective palatal shield made of flowable resin helps reduce pain and improve healing after free gingival graft harvest.

  Recruiting Cairo University · Cairo, Cairo Governorate · NCT07926516

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• Perfusion Index to Measure Postoperative Pain in Kids After Adenotonsillectomy

  This study tests whether the perfusion index can reliably reflect pain levels in children aged 1–12 after adenotonsillectomy, comparing standard care with an added glossopharyngeal nerve block.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07915804

• Anterior Knee Nerves Block vs Femoral Nerve Block for Knee Arthroscopy

  This trial tests whether an anterior nerves of the knee (ANK) block provides similar pain relief to a femoral nerve block after knee arthroscopy in adults, aiming to reduce quadriceps weakness.

  Recruiting Van Training and Research Hospital · Van · NCT07910500

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.